CARL
Carlsmed, Inc. · Healthcare · Health Information Services
Last
$16.89
+$0.14 (+0.81%) 4:00 PM ET
After hours $16.65 −$0.24 (−1.39%) 7:39 PM ET
Prev close $16.75
Open $16.71
Day high $17.00
Day low $16.62
Volume 121,234
Avg vol 148,510
Mkt cap
$460.87M
EV/Sales
6.79
P/E ratio
-12.70
FY Revenue
$63.30M
EPS
-1.33
Gross Margin
76.63%
Div yield
0.00%
Sector
Healthcare
AI report sections
CARL
Carlsmed, Inc.
CARL has shown positive price performance across the one-, three-, six-, and twelve-month periods, with the latest close above short- and intermediate-term moving averages and accompanied by above-average volume. However, an RSI near 74 indicates elevated momentum conditions, while operating losses and negative free cash flow create a material contrast between market momentum and underlying profitability.
AI summarized at 12:41 AM ET, 2026-08-20
AI summary scores
INTRADAY: 68 SWING: 70 LONG: 33
Volume vs average
Intraday (cumulative)
−23% (Below avg)
Vol/Avg: 0.77×
RSI
74.54 (Overbought)
Overbought (>70)
MACD momentum
Intraday
+0.00 (Strong)
MACD: 0.01 Signal: 0.00
Short-Term
+0.16 (Strong)
MACD: 1.12 Signal: 0.96
Long-Term
+0.23 (Strong)
MACD: 1.52 Signal: 1.29
Intraday trend score 62.84

Latest news

CARL 3 articles Positive: 3 Neutral: 0 Negative: 0
Positive GlobeNewswire Inc. • Carlsmed, Inc.
Carlsmed Announces U.S. Launch of its aprevo® Technology Platform for Cervical Fusion Surgeries at the Cervical Spine Research Society (CSRS) 53rd Annual Meeting

Carlsmed launched its aprevo® Technology Platform for cervical fusion surgeries, featuring AI-driven preoperative planning and 3D-printed patient-specific implants. The platform aims to improve surgical outcomes and precision in spine procedures.

CARL spine surgery AI personalized medicine medical technology cervical fusion
Sentiment note

Company launched innovative medical technology platform, completed first 50+ clinical cases, received positive clinical feedback, and demonstrated potential to transform spine surgery standard of care

Positive GlobeNewswire Inc. • Mike Cordonnier
Carlsmed, Inc. Appoints Jennifer Kamocsay as Chief Legal Officer and Secretary

Carlsmed has appointed Jenifer Kamocsay as Chief Legal Officer and Secretary, bringing over two decades of corporate legal experience from life science and technology sectors to strengthen the company's leadership team.

CARL PRGS legal appointment corporate governance spine surgery AI technology
Sentiment note

Company is expanding leadership, strengthening organizational capabilities, and preparing for commercial launch with an experienced legal professional

Positive GlobeNewswire Inc. • Mike Cordonnier
Carlsmed, Inc. Selected for Inclusion in Russell 2000® Index

Carlsmed, a medical technology company specializing in AI-enabled personalized spine surgery solutions, was added to the Russell 2000 Index following its IPO in July 2025.

CARL AI spine surgery medical technology Russell 2000 Index IPO
Sentiment note

Company achieved significant milestone by being added to Russell 2000 Index, indicating growth potential and market recognition

News and sentiment labels describe article tone and are provided for research purposes only. They are not trading recommendations or forecasts.
Trade Ranks, LLC is not a registered investment adviser or broker-dealer. All rankings and AI reports are for informational and educational purposes only and are not personalized advice. Investing involves risk. Policy Portal